Nan Geng1, Wenxia Hu1, Zhikun Liu2, Jingwei Su2, Wenyu Sun3, Shaonan Xie4, Cuimin Ding1,*
Oncologie, Vol.22, No.4, pp. 245-254, 2020, DOI:10.32604/oncologie.2020.014125
Abstract Objective: This study was set out to inquire into the expression and
clinical significance of lncRNA activated by transforming growth factor β
(LncRNA-ATB) and in cancer tissues of patients with non-small cell lung cancer
(NSCLC). Methods: LncRNA-ATB in cancer tissues and adjacent tissues of 89
NSCLC patients was detected by quantitative real-time polymerase chain reaction
(qRT-PCR), and its clinical diagnostic value in NSCLC was determined by receiver
operating characteristic (ROC) curves. Based on the median expression of LncRNAATB in NSCLC tissues, 89 patients were allocated into high- and low-expression
groups. The 3-year survival rate was calculated using Kaplan-Meier method and… More >
Login
Register
